Home
Conditions
Chemotherapy-induced Neutropenia

Clinical trial condition

Chemotherapy-induced Neutropenia

Explore clinical trials studying Chemotherapy-induced Neutropenia. Study availability and eligibility vary by location and protocol.

31 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Chemotherapy-induced Neutropenia trial results

Completed

Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

NCT02643901

Conditions: Chemotherapy-induced Neutropenia
Locations: Tianjin Hematonosis Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

NCT03246009

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations: Chinese Academy of Medical Sciences Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

NCT01735175

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +13 more
Locations: Sandoz Investigational Site Ijuí, Brazil

Sandoz Investigational Site Lajeado, Brazil

Sandoz Investigational Site Santo André, Brazil

Sandoz Investigational Site Andhra Pradesh, India

View all 41 locations

View Trial Details

Completed

Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein

NCT02465801

Conditions: Chemotherapy-induced Neutropenia
Locations: Cancer Hospital, Chinese Academy of Medical Scienses Beijing, China

View Trial Details

Completed

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

NCT01569087

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations: Arkhangelsk District Clinical Oncology Dispensary Arkhangelsk, Russia

Perm Region Oncology Dispensary Perm, Russia

N.N.Petrov Oncology Research Center Saint Petersburg, Russia

Russian scientific center of radiology and surgery technologies Saint Petersburg, Russia

View Trial Details

Completed

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

NCT02104830

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations: Arkhangelsk District Clinical Oncology Dispensary Arkhangelsk, Russia

Clinical Hospital at Chelyabinsk Railway Station Chelyabinsk, Russia

State public health institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of the Republic of Tatarstan Kazan', Russia

Non-governmental healthcare institution "Central Clinical Hospital № 2 Semashko" JSC "Russian Railways" Moscow, Russia

View all 13 locations

View Trial Details

Completed

Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers

NCT02700360

Conditions: Agranulocytosis, Chemotherapy-induced Neutropenia, Cytopenia, +6 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Completed

Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

NCT02156388

Conditions: Chemotherapy-induced Neutropenia, Metastatic Tumors, Neoplasm Metastasis, +4 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

NCT02532712

Conditions: Agranulocytosis, Chemotherapy-induced Neutropenia, Cytopenia, +6 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Completed

A Safety and PK Study of EC-18 in Healthy Subjects

NCT02496143

Conditions: Chemotherapy-induced Neutropenia
Locations: Carolina Phase I Clinical Research Raleigh, North Carolina, United States

View Trial Details

Chemotherapy-induced Neutropenia

Chemotherapy-induced Neutropenia trial results

Related conditions